Skip to content

Evaluation of Neem Caplets in the treatment of Acne Vulgaris

To Evaluate The Efficacy of Neem Caplets in the Treatment of Acne Vulgaris: A Double Blind Comparative Study

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2011/06/001806
Enrollment
50
Registered
2011-06-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Acne Vulgaris

Interventions

Intervention1: Neem Caplet: Dose - 1 Neem caplet per day Duration of treatment - 4 weeks Mode of administration - Oral Control Intervention1: Placebo: Dose - 1 Placebo caplet per day Duration of treat

Sponsors

The Himalaya Drug Company
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of either sex, aged more than or equal to 18 years suffering from acne vulgaris will be included in the study.

Exclusion criteria

Exclusion criteria: Women who are pregnant,nursing an infant or an individual who is not willing to follow the required contraceptive method during the course of the trial.

Design outcomes

Primary

MeasureTime frame
Improvement in the symptoms of Acne vulgarisTimepoint: 4 weeks

Secondary

MeasureTime frame
Improvement in the symptoms of Acne vulgarisTimepoint: 4 weeks

Countries

India

Contacts

Public ContactDr Mangala Lahkar
dr_mlahkar@rediffmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026